share_log

HC Wainwright & Co. Reiterates Buy on Pyxis Oncology, Maintains $7 Price Target

Moomoo 24/7 ·  Apr 10 06:09

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Pyxis Oncology (NASDAQ:PYXS) with a Buy and maintains $7 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment